You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 287 No. 6, February 13, 2002 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (2)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in JAMA

Drug-Related Hyperglycemia

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their Contempo Updates article about drug-induced hyperglycemia,1 Drs Luna and Feinglos did not mention glucosamine sulfate, a drug that is increasingly used in the treatment of osteoarthritis.2

By increasing glucose flux through the hexosamine biosynthetic pathway, glucosamine has been shown to induce insulin resistance in skeletal muscle.3 Furthermore, acceleration of the hexosamine pathway also inhibits glucose-induced insulin secretion, resulting in hyperglycemia.4 In a case report of a patient with disabling hypoglycemic symptoms caused by metastatic insulinoma, the use of glucosamine for osteoarthritis led to marked improvement of these symptoms.5 In industrialized countries where people are becoming increasingly overweight and thus at increased risk of osteoarthritis, the diabetogenic effect of glucosamine must be considered.

N. Norman Chan, MRCP; Risa Osaki, MRCP; C. C. Chow, FRCP; Juliana C. N. Chan, MD,FRCP; Clive S. Cockram, MD,FRCP
Department of Medicine and Therapeutics
Prince of Wales Hospital
Hong Kong

1. Luna B, Feinglos MN. Drug-induced hyperglycemia. JAMA. 2001;286:1945-1948. FREE FULL TEXT
2. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised placebo-controlled clinical trial. Lancet. 2001;357:251-256. FULL TEXT | ISI | PUBMED
3. Monauni T, Zenti MG, Cretti A, et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes. 2000;49:926-935. ABSTRACT
4. Giaccari A, Morviducci L, Zorretta D, et al. In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia. Diabetologia. 1995;38:518-524. ISI | PUBMED
5. Chan NN, Baldeweg SE, Tan TMM, Hurel SJ. Glucosamine sulphate and osteoarthritis. Lancet. 2001;357:1618-1619.


To the . . . [Full Text of this Article]


RELATED ARTICLE

Drug-Induced Hyperglycemia
Beatriz Luna and Mark N. Feinglos
JAMA. 2001;286(16):1945-1948.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Effect of Glucosamine-Chondroitin Supplementation on Glycosylated Hemoglobin Levels in Patients With Type 2 Diabetes Mellitus: A Placebo-Controlled, Double-blinded, Randomized Clinical Trial
Scroggie et al.
Arch Intern Med 2003;163:1587-1590.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2002 American Medical Association. All Rights Reserved.